The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production. 1986

F Hashimoto, and Y Sakiyama, and S Matsumoto

The effect of the supplementation with several gammaglobulin (GG) preparations on the in vitro immunoglobulin synthesis of peripheral blood mononuclear cells (PBMC) from normal subjects stimulated with pokeweed mitogen (PWM) was studied. Among the GG preparations used in this study, immune serum globulin (ISG) demonstrated the most suppressive effect, and S-sulfonation and polyethylene glycol (PEG)-treated preparations also had a suppressive effect. However, the preparation of pepsin degradation had no suppressive effect. And because IgG F(ab')2 fragments also failed to induce the suppressive effect, it was considered to be triggered by the attachment of the Fc portion of GG to the corresponding membrane receptor. To determine the cellular targets, PBMC were fractionated into E-rosetting cells (T cells) and non E-rosetting cells (B cells). The suppressive effect was induced by pre-incubation of either T cells or B cells with the GG preparations for 1 h, at 37 degrees C in PWM-induced immunoglobulin (Ig) production. The failure of T cells pretreated with OKT8 monoclonal antibody and complement to induce the suppressive effect suggested that T8 positive T cells are one of the effector cells involved. The activation step of the suppressive effect was prostaglandin E2-independent, and as effector cells contain an Fc receptor which is sensitive to pronase, it was suggested that monocytes were not involved in this activation process. Our observations further suggested that the Ig effects of GG therapy are not limited to antibody transfer, since GG preparations also suppress directly the differentiation of B cells and induce suppressor T cells in in vitro immunoglobulin production stimulated with PWM.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011043 Pokeweed Mitogens Proteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells. Lectins, Pokeweed,Pokeweed Lectin,Pokeweed Lectins,Pokeweed Mitogen,Pokeweed Mitogen Isolectin,Isolectin, Pokeweed Mitogen,Lectin, Pokeweed,Mitogen Isolectin, Pokeweed,Mitogen, Pokeweed,Mitogens, Pokeweed
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Hashimoto, and Y Sakiyama, and S Matsumoto
January 1984, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
F Hashimoto, and Y Sakiyama, and S Matsumoto
December 1981, Immunopharmacology,
F Hashimoto, and Y Sakiyama, and S Matsumoto
November 1986, Journal of clinical & laboratory immunology,
F Hashimoto, and Y Sakiyama, and S Matsumoto
January 1979, The Journal of rheumatology. Supplement,
F Hashimoto, and Y Sakiyama, and S Matsumoto
August 1983, Journal of immunology (Baltimore, Md. : 1950),
F Hashimoto, and Y Sakiyama, and S Matsumoto
January 1985, Biology of the neonate,
F Hashimoto, and Y Sakiyama, and S Matsumoto
October 1986, Cellular immunology,
Copied contents to your clipboard!